Author

Steve Wisseh

COMPARISON OF REAL-WORLD TREATMENT PERSISTENCE AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR-ALPHA TREATMENT IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN’S DISEASE: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
COMPARISON OF REAL-WORLD TREATMENT PERSISTENCE AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR-ALPHA TREATMENT IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN’S DISEASE: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

Steve Wisseh  et al.

LONG-TERM, REAL-WORLD TREATMENT PERSISTENCE AND MUCOSAL HEALING RATES WITH VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
LONG-TERM, REAL-WORLD TREATMENT PERSISTENCE AND MUCOSAL HEALING RATES WITH VEDOLIZUMAB IN PATIENTS WITH CROHN’S DISEASE: SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

Steve Wisseh  et al.

Item 1 - 2 / 2
1